Progress Report – ACCURATE Study – March 2023

ACCURATE Study (UroCCR No. 99)

With 12,000 new cases diagnosed annually in France, kidney cancer ranks as the third  most common urological tumour in adults. In recent years, minimally invasive kidney-sparing surgery using robotic assistance has become the preferred treatment approach.

The ACCURATE study aims to further improve the quality of surgical procedures by guiding the surgeon with advanced 3D modelling.

A total of 28 patients have been included in the study since January 2023.

▶ 18+ new patients in March 2023.

Many thanks to everyone for your continued involvement!